TY - JOUR
T1 - Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway
AU - Lessard, Frédéric
AU - Igelmann, Sebastian
AU - Trahan, Christian
AU - Huot, Geneviève
AU - Saint-Germain, Emmanuelle
AU - Mignacca, Lian
AU - Del Toro, Neylen
AU - Lopes-Paciencia, Stéphane
AU - Le Calve, Benjamin
AU - Montero, Marinieve
AU - Deschënes-Simard, Xavier
AU - Bury, Marina
AU - Moiseeva, Olga
AU - Rowell, Marie-Camille
AU - Oeffinger, Marlene
AU - Zorca, Cornelia E.
AU - Zenklusen, Daniel
AU - Brakier-Gingras, Léa
AU - Bourdeau, Véronique
AU - Ferbeyre, Gerardo
N1 - Funding Information:
We thank D. P. Baker (Biogen Idec), D. A. Galloway (Fred Hutchinson Cancer Center), N. Bardeesy (MGH), S. Lowe (MSK), A. Koff (MSK), T. Moss (U. Laval), I. Topisirovic, P. Chartrand (U. Montréal), V. Blank (McGill University) and B. Weinberg (MIT) for comments and/or reagents. We thank É. Bonneil, F. McManus and the IRIC Proteomics Core Facility for proteomic analysis. We thank J. Hinsinger, M. Birlea and the IRIC Histology Core Facility for immunohistochemistry. F.L. is supported by FRQS (Fonds de Recherche du Québec-Santé) and the CRS (Cancer Research Society). G.F. is supported by FRQS. Work was funded by grants from the CIHR (Canadian Institute of Health and Research: CIHR MOP11151) to G.F., (Canadian Institutes of Health Research: CIHR
Funding Information:
We thank D. P. Baker (Biogen Idec), D. A. Galloway (Fred Hutchinson Cancer Center), N. Bardeesy (MGH), S. Lowe (MSK), A. Koff (MSK), T. Moss (U. Laval), I. Topisirovic, P. Chartrand (U. Montr?al), V. Blank (McGill University) and B. Weinberg (MIT) for comments and/or reagents. We thank . Bonneil, F. McManus and the IRIC Proteomics Core Facility for proteomic analysis. We thank J. Hinsinger, M. Birlea and the IRIC Histology Core Facility for immunohistochemistry. F.L. is supported by FRQS (Fonds de Recherche du Qu?bec-Sant?) and the CRS (Cancer Research Society). G.F. is supported by FRQS. Work was funded by grants from the CIHR (Canadian Institute of Health and Research: CIHR MOP11151) to G.F., (Canadian Institutes of Health Research: CIHR MOP106628) to M.O. and the CCSRI (Canadian Cancer Society Research Institute: 704223) to G.F.
Publisher Copyright:
© 2018 The Author(s).
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Cellular senescence is a tumour suppressor programme characterized by a stable cell cycle arrest. Here we report that cellular senescence triggered by a variety of stimuli leads to diminished ribosome biogenesis and the accumulation of both rRNA precursors and ribosomal proteins. These defects were associated with reduced expression of several ribosome biogenesis factors, the knockdown of which was also sufficient to induce senescence. Genetic analysis revealed that Rb but not p53 was required for the senescence response to altered ribosome biogenesis. Mechanistically, the ribosomal protein S14 (RPS14 or uS11) accumulates in the soluble non-ribosomal fraction of senescent cells, where it binds and inhibits CDK4 (cyclin-dependent kinase 4). Overexpression of RPS14 is sufficient to inhibit Rb phosphorylation, inducing cell cycle arrest and senescence. Here we describe a mechanism for maintaining the senescent cell cycle arrest that may be relevant for cancer therapy, as well as biomarkers to identify senescent cells.
AB - Cellular senescence is a tumour suppressor programme characterized by a stable cell cycle arrest. Here we report that cellular senescence triggered by a variety of stimuli leads to diminished ribosome biogenesis and the accumulation of both rRNA precursors and ribosomal proteins. These defects were associated with reduced expression of several ribosome biogenesis factors, the knockdown of which was also sufficient to induce senescence. Genetic analysis revealed that Rb but not p53 was required for the senescence response to altered ribosome biogenesis. Mechanistically, the ribosomal protein S14 (RPS14 or uS11) accumulates in the soluble non-ribosomal fraction of senescent cells, where it binds and inhibits CDK4 (cyclin-dependent kinase 4). Overexpression of RPS14 is sufficient to inhibit Rb phosphorylation, inducing cell cycle arrest and senescence. Here we describe a mechanism for maintaining the senescent cell cycle arrest that may be relevant for cancer therapy, as well as biomarkers to identify senescent cells.
UR - http://www.scopus.com/inward/record.url?scp=85048977092&partnerID=8YFLogxK
U2 - 10.1038/s41556-018-0127-y
DO - 10.1038/s41556-018-0127-y
M3 - Article
SN - 1476-4679
VL - 20
SP - 789
EP - 799
JO - nature cell biology
JF - nature cell biology
IS - 7
ER -